Sartorius AG

DE

SATG

Health Care

58.89 ₽

Current price

Strong sell
58.89 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    186 / 240

  • Position in country

    858 / 963

  • Return on Assets, %

    4

    -2.7

  • Debt to Equity, %

    256.9

    15.1

  • Intangible assets and goodwill, %

    56.5

    4.7

  • Revenue CAGR 3Y, %

    13.2

    12.8

  • Total Equity change 1Y, %

    7.1

    -2.4

  • Revenue Y, % chg

    -16.1

    0

  • P/E

    85.7

    32.1

  • P/BV

    8.5

    2

  • P/S

    5.6

    4.1

  • EV/S

    8.1

    3.6

  • EV/EBITDA

    28.8

    7.8

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    434.4

    48.9

  • Forward P/E

    44.1

    25.5

  • Dividend Yield, %

    0.2

    0.8

  • Forward Dividend Yield, %

    1.8

    0.2

  • Expected dividend per share

    1.3

    0

  • Dividend Ex Date

    2024-04-02

Get an analytical review of this company

Competitors

Ranks

  • Lonza Group AG

    00%

  • Samsung Biologics Co Ltd

    00%

  • Gerresheimer AG

    00%

  • IQVIA Holdings Inc

    00%

  • Agilent Technologies Inc

    00%

  • SCHOTT Pharma AG & Co KgaA

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Sartorius AG

    00%

  • Evotec SE

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Germany

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    23805.2

  • Ticker

    SOAGY.PK

  • ISIN

    US80385Q2084

  • IPO date

    1999-04-01

  • Availability on Russian exchanges

    No

  • Reporting for

  • Date fact. publication of reports

Company Description

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, and filter technology for clarification, among others. The Lab Products and Services segment provides instruments, consumables and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation and membrane filter systems for sterility testing of parenterals.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: